Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CLZR:a potential 10 bagger? -- Ignore unavailable to you. Want to Upgrade?

To: Quad Sevens who wrote (117)	4/22/1999 3:25:00 PM
From: Quad Sevens	Respond to of 315

I love the smell of a new high in the morning. OK, former resistance becomes new support. Allegedly. Let's see if we can hold the 10 and change area. We're in uncharted waters and we got turnaround, value, demographics, and even the momos see CLZR now.

To: Quad Sevens who wrote (117)	4/22/1999 4:10:00 PM
From: Musti	Read Replies (1) \| Respond to of 315

With 4 straight quarters of explosive growth, it seems to me that Candela should be valued at a minimum of 3 times sales -- which would put the stock price at $30+. Same scenario holds true for those who prefer P/E valuations -- still a $30+ stock price target.